Xueyang Jiang

Dual GSK-3β/AChE Inhibitors as a New Strategy for Multitargeting Anti-Alzheimer’s Disease Drug Discovery

Xueyang Jiang, Tingkai Chen, Junting Zhou et al. · ACS Medicinal Chemistry Letters · 2018 · 119 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Targeted degradation of anaplastic lymphoma kinase by gold nanoparticle-based multi-headed proteolysis targeting chimeras

Yingming Wang, Lingfei Han, Fulei Liu et al. · Colloids and Surfaces B Biointerfaces · 2020 · 74 citations

Life Sciences, Biochemistry, Oncology +13

PROTACs suppression of GSK-3β, a crucial kinase in neurodegenerative diseases

Xueyang Jiang, Junting Zhou, Yang Wang et al. · European Journal of Medicinal Chemistry · 2020 · 61 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Design and synthesis of novel indole and indazole-piperazine pyrimidine derivatives with anti-inflammatory and neuroprotective activities for ischemic stroke treatment

Hongwei Wang, Enjing Cui, Jiaming Li et al. · European Journal of Medicinal Chemistry · 2022 · 40 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Rational design and biological evaluation of a new class of thiazolopyridyl tetrahydroacridines as cholinesterase and GSK-3 dual inhibitors for Alzheimer’s disease

Xueyang Jiang, Junting Zhou, Yang Wang et al. · European Journal of Medicinal Chemistry · 2020 · 39 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14